| 1Labetalol |
|---|
Compound Name Labetalol |
CID 3869 |
Molecular Formula C19H24N2O3 |
Molecular Weight 328 |
No. Chiral Centers: 2 |
No. Hydrogen Bond Acceptors 4 |
No. Hydrogen Bond Donors 4 |
Applications
Labetalol
5255
Separation Mode: Chiral
Chiral
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine
HPLC
Antihypertensive Agents
Pharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 5255)
Column: | ||||||||||
Brand Name: | ||||||||||
Part No: | ||||||||||
Phase Name: 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine | ||||||||||
Elution Type: Isocratic | ||||||||||
Mobile Phase: A: Hexane B: 1,2-Dichloroethane C: Ethanol-trifluoroacetic acid | ||||||||||
Gradient Profile:
| ||||||||||
Flow Rate: 1 mL/min | ||||||||||
Temperature: 22°C | ||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 308 nm (22°C) |
Order Items Used in This Application
00G-3020-E0
Chirex (S)-LEU and (R)-NEA, LC Column 250 x 4.6 mm, Ea
Qty:
Similar Applications
search
Labetalol
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
